Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.

@article{Schubert2003OsteoporosisIM,
  title={Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.},
  author={Markus Schubert and Catharina Bullmann and Timo Minnemann and Christopher Reiners and Wilhelm Krone and Friedrich Jockenh{\"o}vel},
  journal={Hormone research},
  year={2003},
  volume={60 1},
  pages={21-8}
}
BACKGROUND No randomized study exists comparing the effects of different modes of androgen substitution on bone mineral density (BMD). METHODS We performed a prospective, randomized, trial assigning 53 hypogonadal men to the following treatment groups: mesterolone 100 mg p.o. daily, testosterone undecanoate 160 mg p.o. daily, testosterone enanthate 250 mg i.m. every 21 days, or a single subcutaneous implantation of 1,200 mg crystalline testosterone. The BMD was determined by peripheral… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 35 references

The influence of growth hormone deficiency , growth hormone replacement therapy , and other aspects of hypopituitarism on fracture rate and bone mineral density

  • HJ Behre, S Kliesch, E Leifke, TM Link, E Nieschlag
  • J Bone Miner Res
  • 2001

hypopituitarism on fracture rate and bone mineral density

  • HJ Behre, S Kliesch, E Leifke, TM Link, E Nieschlag
  • J Bone Miner Res
  • 2001

Growth hormone , insulin - like growth factors and bone metabolism

  • T Rosen, L Wilhelmsen, K Landin-Wilhelmsen, G Lappas, BA Bengtsson
  • 1996

Similar Papers

Loading similar papers…